An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer.
Saved in:
| Title: | An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer. |
|---|---|
| Authors: | Liu, Joyce1 (AUTHOR) joyce_liu@dfci.harvard.edu, Burris, Howard2 (AUTHOR), Wang, Judy S.3 (AUTHOR), Barroilhet, Lisa4 (AUTHOR), Gutierrez, Martin5 (AUTHOR), Wang, Yulei6 (AUTHOR), Vaze, Anjali6 (AUTHOR), Commerford, Renee6 (AUTHOR), Royer-Joo, Stephanie6 (AUTHOR), Choeurng, Voleak6 (AUTHOR), Humke, Eric1,6 (AUTHOR), Moore, Kathleen7 (AUTHOR) |
| Source: | Gynecologic Oncology. Dec2021, Vol. 163 Issue 3, p473-480. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
